NCT05665426

Brief Summary

Low back pain is a common clinical condition, with up to 84% of adults experiencing varying degrees of low back pain. The most common form of low back pain is non-specific low back pain, which is often treated symptomatically in medicine due to its lack of etiology, which has many side effects. In contrast, acupuncture has the advantage of being practical and free of side effects. The use of acupuncture points in the lumbar region has a long history of application, as early as the《Huangdi Neijing》thousands of years ago. In the Ming Dynasty, there were summaries of the experience of " Yaobei Weizhong Qiu" (Which means the Weizhong point is closely associated with the waist). Weizhong point's efficacy in lumbar diseases (e.g., lumbar disc herniation, lumbago, sciatica, etc.) is still confirmed. One of the mechanisms is closely related to the improvement of microcirculation, which can be visualized by observing changes in infrared thermal parameters. Acupuncture and moxibustion are the most common therapies at Weizhong point, but there is a lack of research on the differences in efficacy between the two. Therefore, this study aims to collect the temperature parameters of the lumbar region in healthy subjects after acupuncture/moxibustion to estimate the difference in the therapeutic effect on the lumbar region, which can help to reveal the effect differences between acupuncture and moxibustion. As well as to provide scientific evidence to enrich the connotation of the classical theory " Yaobei Weizhong Qiu." the investigators will test the following hypotheses:

  1. 1.Hypotheses for main effects of different point selection(LU 5 and BL 40): H1: There is a significant difference in average temperature change at the waist at 30 minutes between the Weizhong(BL 40) group and the Chize(LU 5) group.
  2. 2.Hypotheses for the main effects of different interventions (acupuncture and moxibustion) H1: There is a significant difference in average temperature change at the waist at 30 minutes between the acupuncture group and the moxibustion group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 27, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

April 14, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2023

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

October 1, 2025

Completed
Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

2 months

First QC Date

December 14, 2022

Results QC Date

August 25, 2025

Last Update Submit

September 11, 2025

Conditions

Keywords

acupuncture; moxibustion; Weizhong; waist

Outcome Measures

Primary Outcomes (1)

  • ΔT at the Waist Between 30 Minutes and the Baseline.

    The temperature difference (ΔT)at the waist between 30 minutes and the baseline.

    30 minutes after the intervention has begin

Secondary Outcomes (4)

  • δT of The Maximum Temperature in the Designated Area of the Waist After 30 Minutes.

    30 minutes after the intervention has begin

  • The Temperature at the Waist Between 5 ,10 ,15 ,20 ,25, 30 Minutes and Baseline.

    5 minutes,10 minutes,15 minutes,20 minutes,25 minutes , 30 minutes after the intervention has begin

  • ΔT at the Governor Vessel Between 30 Minutes and Baseline

    30 minutes after the intervention has begin

  • Number of Participants Reporting a Sensation of Warmth in the Lower Back

    Immediately after completion of the intervention session (within 5 minutes of needle withdrawal).

Study Arms (4)

AW group

OTHER

(1) AW group: acupuncture at Weizhong point,

Other: acupuncture

AC group

OTHER

(2) AC group: acupuncture at Chize point,

Other: acupuncture

MW group

OTHER

(3) MW group: moxibustion at Weizhong point,

Other: moxibustion

MC group

OTHER

(4) MC group: moxibustion at Chize point.

Other: moxibustion

Interventions

Patients allocated to the acupuncture group will be punctured at the pre-specified acupoints. According to the theory of traditional Chinese medicine and clinical experience, we will use the Bilateral Weizhong point (BL 40). Because of the similar anatomy, the Chize point (LU 5) was chosen as a control. Sterile disposable stainless steel acupuncture needles (length: 40 mm, diameter: 0.25 mm; Hwato, Suzhou, China) will be used.

AC groupAW group

Moxibustion Participants in the moxibustion group will receive moxibustion treatment via portable Moxibustion (Aikeshu, Bozhou, China); the moxibustion is composed of The inner tube (containing the moxa pillar) and the outer tube. To use, pull out the inner tube and light the moxa pillar, then insert the outer tube and fix the moxibustion on the acupuncture points. Two Moxibustion devices will be sequentially applied at two acupoints Weizhong (BL 40) and Chize (LU 5), for 30 minutes.

MC groupMW group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • aged 18-60 (either sex);
  • with a BMI of 18.5-23.9 kg/m2;
  • with no history of lower back pain;
  • with normal range of lumbar mobility (including flexion from 75-90 degrees, extension of 30 degrees, lateral bending from 20-35 degrees, and unilateral rotation of 90 degrees);
  • willing to participate in the trial and have signed the informed consent form.

You may not qualify if:

  • participants with serious heart, liver, kidney, or hematological diseases;
  • women in menses, pregnancy, or lactation;
  • those unable to complete the imaging in prone position (about 40 minutes);
  • those with cognitive impairments;
  • those with a history of lower back trauma or whiplash within a week;
  • those with skin diseases or skin lesions, sensory impairments, scarring, or neoplasms at the test site;
  • those with metal allergies
  • those who have participated in other clinical trials that may affect the results of the study within the last three weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Ethics Board of The Third Affiliated Hospital of Zhejiang Chinese Medicinal University

Hangzhou, Zhejiang, 310000, China

Location

Related Publications (2)

  • Zheng SY, Wang XY, Lin LN, Liu S, Huang XX, Liu YY, Yu XS, Pan W, Fang JQ, Liang Y. Lumbar temperature change after acupuncture or moxibustion at Weizhong (BL40) or Chize (LU5) in healthy adults: A randomized controlled trial. J Integr Med. 2025 Mar;23(2):145-151. doi: 10.1016/j.joim.2025.01.004. Epub 2025 Jan 16.

  • Zheng S, Shen Q, Lyu Z, Tian S, Huang X, Liu Y, Yu X, Pan W, Nie N, Liang Y, Fang J. Effect of acupuncture or moxibustion at Acupoints Weizhong (BL40) or Chize (LU5) on the change in lumbar temperature in healthy adults: A study protocol for a randomized controlled trial with a 2 x 2 factorial design. PLoS One. 2023 Oct 30;18(10):e0291536. doi: 10.1371/journal.pone.0291536. eCollection 2023.

MeSH Terms

Interventions

Acupuncture TherapyMoxibustion

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Results Point of Contact

Title
Siyi Zheng
Organization
Zhejiang Chhinese Medicial University

Study Officials

  • Yi Liang, PhD

    The Third Affiliated Hospital of Zhejiang Chinese Medicial University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The eligible patients will be given a sequential study number by research staff. Subsequently, their basic information will be entered into an internet-based and password-protected clinical research management system (ResMan Research Manager, supported by West China Hospital, Sichuan University, China), which will automatically generate a research code and randomly allocate participants to one of four groups (Acu-BL40 group, Acu-LU5 group, Mox-BL40 group or Mox-LU5 group) at a ratio of 1:1:1:1. Given the nature of the intervention, the participants and acupuncturists will be aware of the assignment. The research assistants responsible for data collection, biostatisticians and data analysis will be masked to study group allocation. Precise documentation of therapy will be recorded in the case report forms (CRFs) in an exclusive computer as well as on paper.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2×2 factorial design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D, PhD

Study Record Dates

First Submitted

December 14, 2022

First Posted

December 27, 2022

Study Start

April 14, 2023

Primary Completion

June 25, 2023

Study Completion

June 25, 2023

Last Updated

October 1, 2025

Results First Posted

October 1, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations